MANGOCEUTICALS, INC. (MGRX)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jan. 27, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Mangoceuticals, Inc. that they will not review the company's registration statement filed on January 13, 2026. The SEC emphasizes that the responsibili… | Read Filing EDGAR |
| Jan. 26, 2026 | CORRESP | Neutral/Informational | Moderate | Mangoceuticals, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1. They are seeking to have the registr… | Read Filing EDGAR |
| Jun. 20, 2025 | CORRESP | Neutral/Informational | Moderate | Mangoceuticals, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, initially filed on June 13, 2025. The company aims for th… | Read Filing EDGAR |
| Jun. 20, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Jacob D. Cohen, CEO of Mangoceuticals, Inc., that they will not review the company's registration statement filed on June 13, 2025. The SEC emphasizes … | Read Filing EDGAR |
| Jun. 17, 2025 | CORRESP | Neutral/Informational | High | Mangoceuticals, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1, which was filed on May 30, 2025. The… | Read Filing EDGAR |
| Jun. 6, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Mangoceuticals, Inc. that they will not review the company's registration statement filed on May 30, 2025. The letter emphasizes the company's responsi… | Read Filing EDGAR |